Lewes, DE -- (SBWIRE) -- 01/21/2016 -- Report forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS.

Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:
- Molecular diagnostic test
- POCT
- Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:
- HIV
- Respiratory
- HAIs
- Sexual health
- Tropical diseases
- Hepatitis

In addition, the market is segmented based on products:
- Equipment
- Consumables

According to the report, the growth of the infectious disease testing market in the US is driven by the NAFTA. This agreement has reduced the tariffs, improved the intellectual property rights of the US, and opened government procurement market in Mexico and Canada. It has also created larger market access in North America, new export and investment opportunities, and uniform custom procedures with greater transparency and stronger protection for trade secrets.

Further, the report states that the tax has affected R&D and employment in the medical device industry, leading to minimal innovations in products, and decreased overall profit to the manufacturers.

Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

key players in the Infectious Disease Testing Market in the US: Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche and Siemens Healthcare

Other Prominent Vendors in the market are: Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific and Trinity Biotech.

Market driver
- North America free trade agreement
- For a full, detailed list, view our report

Market challenge
- Medical device excise tax law
- For a full, detailed list, view our report

Market trend
- Development of innovative diagnostics initiatives
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 66 pages and 30 Exhibit "Infectious Disease Testing Market in the US 2015 - 2019" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Infectious disease landscape in the US, Market segmentation by technology, Market segmentation by application, Market segmentation by product, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://www.marketresearchreports.com/technavio/infectious-disease-testing-market-us-2015-2019

Find all Healthcare report at : http://www.marketresearchreports.com/healthcare

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions